NEVVI Medicare utilization intelligence
or

← back

Provider profile

SIMPSON, PAMELA M.D.

Hematology-Oncology · NPI 1639217714 · EASTON, MD

1
Groups
34
Codes · 2024
68,250
Disclosed services

SIMPSON, PAMELA is a Hematology-Oncology in EASTON, MD, a member of 1 medical group, who billed 34 distinct codes to Medicare Part B in 2024.

Groups: AMERICAN ONCOLOGY PARTNERS PA (FORT WAYNE, IN)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

68,250
disclosed services
34
codes billed to Medicare Part B
Prior year · CY2023 19,586 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J9271 Injection, pembrolizumab, 1 mg
J0897 Injection, denosumab, 1 mg
J1437 Injection, ferric derisomaltose, 10 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96372 Injection of drug or substance under skin or into muscle
96375 Injection of additional new drug or substance into vein
J2405 Injection, ondansetron hydrochloride, per 1 mg
96413 Administration of chemotherapy into vein, 1 hour or less
Q5130 Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg
J2919 Injection, methylprednisolone sodium succinate, 5 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J1200 Injection, diphenhydramine hcl, up to 50 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96417 Administration of additional new drug or substance into vein, 1 hour or less
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
J3490 Unclassified drugs
96415 Administration of chemotherapy into vein, each additional hour
96523 Irrigation of implanted venous access drug delivery device
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
36415 Insertion of needle into vein for collection of blood sample
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
99441 Telephone medical discussion with physician, 5-10 minutes
80053 Blood test, comprehensive group of blood chemicals
99442 Telephone medical discussion with physician, 11-20 minutes
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.